Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Preeti Putcha

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Breast Cancer Research : BCR|December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Genes & Development|August 1, 2015
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancersRuth Rodriguez-Barrueco, Jiyang Yu, Laura P Saucedo-Cuevas, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Breast Cancer Research : BCR|December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
Genes & Development|August 1, 2015
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancersRuth Rodriguez-Barrueco, Jiyang Yu, Laura P Saucedo-Cuevas, et al.
Pageof 2